Immunologic and structural analysis of eight novel domain-deletion β3 integrin peptides designed for detection of HPA-1 antibodies

Ghevaert, 2007, Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia, Transfusion, 47, 901, 10.1111/j.1537-2995.2007.01208.x Davoren, 2004, Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia, Transfusion, 44, 1220, 10.1111/j.1537-2995.2004.04026.x Williamson, 1998, The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening, Blood, 92, 2280, 10.1182/blood.V92.7.2280 Turner, 2005, Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a, Transfusion, 45, 1945, 10.1111/j.1537-2995.2005.00645.x Metcalfe, 2003, Nomenclature of human platelet antigens, Vox Sang, 85, 240, 10.1046/j.1423-0410.2003.00331.x Newman, 1989, The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing, J Clin Invest, 83, 1778, 10.1172/JCI114082 Bessos, 2005, Report on the 12th International Society of Blood Transfusion platelet immunology workshop, Vox Sang, 89, 105, 10.1111/j.1423-0410.2005.00672.x Li, 2000, Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor, Blood, 95, 205, 10.1182/blood.V95.1.205 Bowditch, 1992, Localization of a PlA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa, Blood, 79, 559 Valentin, 1995, Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response, Blood, 85, 3028, 10.1182/blood.V85.11.3028.bloodjournal85113028 Watkins, 2002, HPA-1a phenotype–genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope, Blood, 99, 1833, 10.1182/blood.V99.5.1833 Xiong, 2001, Crystal structure of the extracellular segment of integrin alpha Vbeta3, Science, 294, 339, 10.1126/science.1064535 Xiao, 2004, Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics, Nature, 432, 59, 10.1038/nature02976 Jennings, 2006, Production of calmodulin-tagged proteins in Drosophila Schneider S2 cells: a novel system for antigen production and phage antibody isolation, J Immunol Methods, 316, 75, 10.1016/j.jim.2006.08.003 Griffin, 1995, A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library, Blood, 86, 4430, 10.1182/blood.V86.12.4430.bloodjournal86124430 Proulx, 1997, Human monoclonal Fab fragments recovered from a combinatorial library bind specifically to the platelet HPA-1a alloantigen on glycoprotein IIb–IIIa, Vox Sang, 72, 52, 10.1159/000461958 Takagi, 2002, The role of the specificity-determining loop of the integrin beta subunit I-like domain in autonomous expression, association with the alpha subunit, and ligand binding, Biochemistry, 41, 4339, 10.1021/bi016047u Neri, 1995, Calmodulin as a versatile tag for antibody fragments, Biotechnology (NY)., 13, 373 Santoso, 2006, A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1, Transfusion, 46, 790, 10.1111/j.1537-2995.2006.00797.x Metcalfe, 2003, Collaborative studies to establish the first WHO Reference Reagent for detection of human antibody against human platelet antigen-5b, Vox Sang, 84, 237, 10.1046/j.1423-0410.2003.00281.x Allen, 2005, Collaborative study to establish the first international standard for quantitation of anti-HPA-1a, Vox Sang, 89, 100, 10.1111/j.1423-0410.2005.00669.x Smethurst, 2004, Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody, Blood, 103, 903, 10.1182/blood-2003-01-0308 O’Connor, 2006, Selective blockade of glycoprotein VI clustering on collagen helices, J Biol Chem, 281, 33505, 10.1074/jbc.M606480200 Von Dem Borne, 1978, A simple immunofluorescence test for the detection of platelet antibodies, Br J Haematol, 39, 195, 10.1111/j.1365-2141.1978.tb01089.x Garner, 2002, Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia, Blood, 100, 344, 10.1182/blood.V100.1.344 Xiong, 2004, A novel adaptation of the integrin PSI domain revealed from its crystal structure, J Biol Chem, 279, 40252, 10.1074/jbc.C400362200 McRee, 1999, Xta/View/Xfit: a versatile program for manipulating for atomic coordinates and electron density, J. Struct Biol, 125, 156, 10.1006/jsbi.1999.4094 Brunger, 1998, Crystallography & NMR system: a new software suite for macromolecular structure determination, Acta Crystallogr D Biol Crystallogr, 54, 905, 10.1107/S0907444998003254 Terzyan, 2003, Comparison of the three-dimensional structures of a human Bence-Jones dimer crystallized on Earth and aboard US Space Shuttle Mission STS-95, J Mol Recognit, 16, 83, 10.1002/jmr.610 Spiegel, 2001, Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII, Blood, 98, 13, 10.1182/blood.V98.1.13 DeLano WL, Bromberg S. PyMOL User’s Manual. DeLano Scientific LLC, 2004: 1–66. Mazurov, 1996, Stimulation of platelet glycoprotein IIb–IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa, FEBS Lett, 391, 84, 10.1016/0014-5793(96)00709-0 Weiss, 1995, A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2, Tissue Antigens, 46, 374, 10.1111/j.1399-0039.1995.tb03129.x Martin, 2003, Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy, Transplantation, 76, 395, 10.1097/01.TP.0000078895.24606.45 Kiefel, 2001, Platelet alloantibodies in transfused patients, Transfusion, 41, 766, 10.1046/j.1537-2995.2001.41060766.x Kuijpers, 1992, Leucine33–proline33 substitution in human platelet glycoprotein IIIa determines HLA-DRw52a (Dw24) association of the immune response against HPA-1a (Zwa/PIA1) and HPA-1b (Zwb/PIA2), Hum Immunol, 34, 253, 10.1016/0198-8859(92)90024-H Armour, 2006, Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity, Blood, 107, 2619, 10.1182/blood-2005-03-0989 Armour, 2003, Differential binding to human FcgammaRIIa and FcgammaRIIb receptors by human IgG wildtype and mutant antibodies, Mol Immunol, 40, 585, 10.1016/j.molimm.2003.08.004